esmolol
DrugEsmolol 50 mcg/kg/min
Other names: Brevibloc
NCT Number: NCT01628562
It was hypothesized that the use of esmolol as an alternative to remifentanil with sevoflurane inhalation anesthesia during intracranial surgery, could provide better hemodynamic conditions and cause lesser side effects in the perioperative period. It was the main objective of this study to compare the effect of esmolol and remifentanil on the incidence of tachycardia and hypertension and the intraoperative fentanyl consumption. The comparison of postoperative troponine I and creatine phosphokinase levels and EKG changes were the secondary objectives.
Looking for future studies?
Notify Me19 year–80 year
All sexes
Interventional
Phase 4
Diskapi Yildirim Beyazit Teaching and Research Hospital, Ankara, Turkey, Turkey (Türkiye)
During neurosurgical procedures intubation, insertion of the head pins, extubation and the early postoperative period are the time lines in which cerebral autoregulation can be impaired by changes in heart rate and blood pressure. Several anesthetic regimens have been implied to overcome this problem. Remifentanil is used in neurosurgery since it allows early recovery and neurologic evaluation. Esmolol on the other hand is also very short acting, effective to blunt cardiovascular responses during surgery and has no significant effect on intracranial pressure and cerebral blood flow. In addition esmolol is addressed to reduce perioperative ischemia during noncardiac surgery.
It was hypothesized that the use of esmolol as an alternative to remifentanil with sevoflurane inhalation anesthesia during intracranial surgery, could provide better hemodynamic conditions and cause lesser side effects in the perioperative period. It was the main objective of this study to compare the effect of esmolol and remifentanil on the incidence of tachycardia and hypertension and the intraoperative fentanyl consumption. The comparison of postoperative troponine I and creatine phosphokinase levels and EKG changes were the secondary objectives.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Esmolol 50 mcg/kg/min
Other names: Brevibloc
Remifentanil 0.5 mcg/kg/min
Other names: Ultiva
Time frame: during intubation, head pin insertion, extubation, early postoperative period
Time frame: during intubation, head pin insertion, extubation, early postoperative period
Diskapi Teaching and Research Hospital
Other
A Comparison of the Perioperative Hemodynamic Effects of Remifentanil and Esmolol: a Double Blind Randomized Controlled Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07258628
Arrhythmias, Cardiac, Cardiac Conduction System Disease
Ankara, Turkey (Türkiye)
View Trial DetailsNCT07385040
Arrhythmias, Cardiac, Cardiac Conduction System Disease
Karachi, Sindh, Pakistan
View Trial DetailsNCT07097441
Arrhythmias, Cardiac, Cardiac Conduction System Disease
Karachi, Sindh, Pakistan
View Trial DetailsNCT00644644
Arrhythmias, Cardiac, Bradycardia
Nashville, Tennessee, United States
View Trial Details